“We really have a tough target of cutting emissions by 50% by 2030—we need to understand the right path with our suppliers” Nataša Vidmar, SVP and Chief Procurement Officer at AstraZeneca, delivered a clear message at the PSCI Decarbonization Summit:
Cytiva’s third Global Biopharma Index reports a decline in overall industry resilience amid ongoing talent shortages and increasing regulatory pressures. Every two years, Cytiva surveys 1,250 biopharma executives across 22 countries, asking them to rate the industry ecosystem on a
“Outsourcing is about giving the things you don’t excel at to someone who does them exceptionally well. That’s what speeds development and delivery,” says Kindeva’s CEO, Milton Boyer. Milton brings nearly 30 years of pharmaceutical manufacturing experience as a contract
“A strategic partnerships is not a transactional relationship – it’s a partnership that should last. If we incentivise through co-investments and risk sharing, the partner can grow their business while enabling us to achieve cost and volume targets.” – Shilpi
Kindeva has officially opened its expanded metered-dose inhaler (MDI) manufacturing facility at Charnwood Campus in Loughborough, marking an investment in sustainable inhalation therapy manufacturing as the industry transitions toward environmentally-friendly propellants. PharmaSource attended the opening ceremony, which featured a comprehensive
“Sustainability is no longer just a buzzword in the pharmaceutical industry. It’s a critical business imperative,” says Hywel Woolf, Global Sustainability Manager at Sharp Services. “ “We’re seeing it become a golden thread in who organizations are and what they
“The healthcare industry is responsible for 5% of global emissions, which is more than aviation,” says Robert Williams Director of Sustainable Procurement at AstraZeneca. As Vice Chair of the Pharmaceutical Supply Chain Initiative (PSCI), he regularly engages with a wide
The Pharmaceutical Supply Chain Initiative (PSCI) has revealed their latest ‘materiality’ review for the pharma supply chain. PSCI members scored a range of supply chain issues against two categories: 6 leading issues The issues ranked the highest for both financial
Sygnature Discovery, one of North America’s largest drug discovery Contract Research Organisations (CRO), has been recognised with the prestigious EcoVadis Award for Sustainable Excellence, achieving a Bronze rating from the globally respected sustainability ratings platform. Over a three-year period, the
Fred Turco is Vice President of Enterprise Indirects and Sustainable Sourcing Lead at Pfizer. He explains how the company is making progress towards Net Zero by collaborating with suppliers.
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
